{"title": "References: Chronic Urticaria", "author": null, "url": null, "hostname": null, "description": "References: Chronic Urticaria", "sitename": null, "date": "2022-06-01", "cleaned_text": "pseudoallergen diet on urticarial activity and leukotriene levels (2010). Loratadine versus levocetirizine in chronic idiopathic urticaria: a comparative study of the efficacy and safety. Indian J Pharacol, 42(1), 12-16. [https://doi.org/10.4103/0253-7613.62399](https://doi.org/10.4103/0253-7613.62399) Arkwright, P.D. (2009). Anti-CD20 or Clin 123(2), 510-511. [https://doi.org/10.1016/j.jaci.2008.11.043](https://doi.org/10.1016/j.jaci.2008.11.043) Asero, Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective. A preliminary study of cetirizine at licensed (2010). Heparin and Tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study. Int Allergy Immunol, 152(4), 384-389. [https://doi.org/10.1159/000292947](https://doi.org/10.1159/000292947) Asero, R., & Tedeschi, A. (2010). Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a M. (2013). Treatment of refractory chronic urticaria: current and future therapeutic options. Am Dermatol, 14(6), 481-488. [https://doi.org/10.1007/s40257-013-0047-3](https://doi.org/10.1007/s40257-013-0047-3) Augustin, M., & Ehrle and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational & Leccese, F. (2005). Improvement of chronic idiopathic urticaria with L-thyroxine: a new (2004). The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA2LEN taskforce position paper. Allergy, 66, 840-844. [https://doi.org/10.1111/j.1398-9995.2011.02580.x](https://doi.org/10.1111/j.1398-9995.2011.02580.x) Banan, P., Butler, G., & Wu, J. (2014). Retrospective chart review in a cohort of patients with urticarial dermatitis. Aust J Derm, 55(2), 137-139. urticaria. reductions in mast cell Fc epsilon Ben-Shoshan, M., Blinderman, I., A. (2013). Psychosocial factors and chronic spontaneous urticaria: a systematic review. Allergy, 68(2), 31-41. [https://doi.org/10.1111/all.12068](https://doi.org/10.1111/all.12068) Bernstein, J.A, Lang, D.M., Khan, D.A., Craig, T., Dreyfus, D., Hsieh, F., ... Wallace, D. (2014). The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol, 133(5), 1270-1277. [https://doi.org/10.1016/j.jaci.2014.02.036](https://doi.org/10.1016/j.jaci.2014.02.036) Bernstein, J.A., Kavati, A., Tharp, Ortiz, B., MacDonald, K., Denhaerynck, K. & Abraham, I.L. (2018). Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systemic review of 'real-world' evidence. Expert Opinion on Biological Therapy, 18(4), 425-448. J., Depletion using Rituximab (Anti-CD20) K. (1987). Cimetidine and chronic idiopathic R., & Sangasapaviriya, A. (2013). Effect of hydroxychloroquine treatment in the patients with anti-histamine refractory chronic spontaneous urticaria, randomised controlled T., (2017). spontaneous urticaria, randomized single-blinded placebo-controlled trial and an open label Antonova, E., & Chang, E. (2015). Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria. Am J B., Schaaf, B., Herbarth I., ... Heinrich, J. (2013). Epidemiology of urticaria in infants and young children in Germany - Results from the German LISAplus and GINIplus Birth Cohort build-up food challenge - a new diagnostic approach to evaluate pseudoallergic reactions in chronic urticaria: a pilot study: stepwise Aqostinis, F., & Bernardini, (2013) Aetiological factors associated with chronic urticaria (2005). Low dose dapsone in chronic idiopathic urticaria: Preliminary results Rituximab successfully treats refractory chronic autoimmune urticaria caused by N. Vichyanond, Jirapongsananuruk, O. (2014). The natural history of chronic urticaria in childhood: a prospective study. J Chua, M. (2011). Chronic spontaenous urticaria in Powell, D.L. (2016). The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: (2018). Omalizumab updosing allows disease control in refractory patients with chronic spontaneous urticaria. Br J Bianco, & B. and montelukast in monotherapy and plus montelukast in M., Lopez-Escobar, M., Rodriguez, F., & Gonzalez-Lopez, M.A. (2016). Prevalence of thyroid autoimmunity in Spanish patients with chronic idiopathic urticaria: a case-control study involving 343 subjects. J Eur Acad Dermatol Venereol, 30, 692-693. [https://doi.org/10.1111/jdv.12979](https://doi.org/10.1111/jdv.12979) Ditto, A. M., (2007). Hydroxychloroquine in the treatment of 12 patients with severe chronic idiopathic urticaria; a case series. H.M., (1977). [Dietary treatment of patients with chronic urticaria and intolerance to aspirin and food additives.](http://www.ncbi.nlm.nih.gov/pubmed/863074) Dermatologica, 54(5), 308-310. Doshi, D.R., & Weinberger, M.M. (2009). cyclosporine in children with chronic idiopathic Pediatr Dermatol, (1986). Warfarin sodium therapy for chronic urticaria and angioedema. South Med J. 79(3), & Kloepfer, K.M., (2018). Serum sickness-like reaction in a pediatric patient spontaneous urticaria. Peadr All Immunol, Eastman, J., & Jerath, M.R. (2014). Outcomes of Chronic Urticaria Patients Thyssen, J.P. (2017). Cardiovascular risk is not increased in patients with chronic spontaneous urticaria: A retrospective population-based urticaria. Allergy, 53(11), Engin, B., & Ozdemir, M. (2008). Prospective randomised non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic JEADV, 22, 481-486. [https://doi.org/10.1111/j.1468-3083.2007.02510.x](https://doi.org/10.1111/j.1468-3083.2007.02510.x) European product characteristics. human/000606/WC500057298.pdf](http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Product_Information/%20human/000606/WC500057298.pdf). Erbagci, Z. (2002). The leukotriene receptor antagonist of chronic idiopathic A. (1999). effect of heparin skin reactivity F., Allen, P., Kaplan, M.D., Fretwell, R.F., Qu, R & Long, J. (1999). A double-blind, placebo-controlled trial of fexofenadine HCl in the urticaria: a report of two Br chronic idiopathic urticaria: a comparison with oral cetirizine. J. (1991). Cetirizine vs placebo in chronic idiopathic urticaria: a double blind randomized cross-over Barr, R.J. (1986). of doxepin in the treatment of chronic idiopathic urticarial. J placebo in the treatment chronic idiopathic urticaria- M.W. double blind D.M. (2003). Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and (2013). Salicylate elimination diets in children: is food restriction supported by 198(11), 600-602. [https://doi.org/10.1034/j.1398-9995.2000.00116.x](https://doi.org/10.1034/j.1398-9995.2000.00116.x) Green, J.P., & Maasyani, S. (1977). Tricyclic antidepressant drugs block histamine H2 receptors in brain. (1977). Nature, 269(5624), 163-165. [https://doi.org/10.1038/269163a0](https://doi.org/10.1038/269163a0) A., Mitzel-Kaoukhov, & Staubach, P. (2011). Omalizumab-an effective and safe treatment of therapy-resistant spontaneous De Costanza, F. (1994). Loratadine and cetirizine in the Ferrer, M. (2016). Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a and metaanalysis. Br J Dermatol [175(6](https://onlinelibrary.wiley.com/toc/13652133/2016/175/6)), 1153-1165. [https://doi.org/10.1111/bjd.14768](https://doi.org/10.1111/bjd.14768) Hale,T.W., (2012). Medications and Mothers' Milk. 15th Edition. Hall, A., & Marshall, G.D. (2013). A Retrospective review of hydroxychloroquine use in patients with chronic idiopathic urticaria S., & Kumar, B. (2004). Comparative efficacy of cetirizine and fexofenadine in the treatment of Staubach, P., Maurer, M. & Weller, K. (2018). Comparison and Interpretability of the available Urticaria Activity Scores. Allergy, 73(1), 251-255. [https://doi.org/10.1111/all.13271](https://doi.org/10.1111/all.13271) Henz, B.M., & Zuberbier, T. & Greaves, M.W. (1993). Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med, S., & Reisner, C. (2005). The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol, 115(3), 459-465. [https://doi.org/10.1016/j.jaci.2004.11.053](https://doi.org/10.1016/j.jaci.2004.11.053) Hrabak, of high-dose intravenous immunoglobulin for chronic spontaneous urticaria. Ann Allergy 105(3), 245. [https://doi.org/10.1016/j.anai.2010.05.018](https://doi.org/10.1016/j.anai.2010.05.018) Hsu, M.L., & Li, L.F. (2012). Prevalence of food avoidance and food allergy in Chinese patients with chronic urticaria. Br J E., & Eisner, M.D. (2012). Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: A prospective study of 2 matched cohorts. Am J Epidem 176(11), Rothman, Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma. J Allergy Clin Immnuol 139(5), 1489-1495. [https://doi.org/10.1016/j.jaci.2016.07.038](https://doi.org/10.1016/j.jaci.2016.07.038) Jaffer, Hudes, G., de Vos, G., & Rosenstreich, D. (2009). The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticarial. Ann Allergy Asthma Immunol, 102(6), 475-482. A., Sastre, J., Bartra, J., ... Valero, A. (2014). Assessment of severity and quality of life in chronic urticaria. Journal of Investigational & Vichyanond, P. (2010). Identification of the etiologies of chronic urticaria in children: a prospective study patients. Pediatr Immunol, 21(3), 508-514. [https://doi.org/10.1111/j.1399-3038.2009.00912.x](https://doi.org/10.1111/j.1399-3038.2009.00912.x) Juhlin, L. (1981). Recurrent patients. Br J Dermatol, 104(4), 369-381. [https://doi.org/10.1111/j.1365-2133.1981.tb15306.x](https://doi.org/10.1111/j.1365-2133.1981.tb15306.x) Juhlin, L., & Arendt, C. chronic urticaria with cetirizine Ther 13 (1), 81-86. [https://pubmed.ncbi.nlm.nih.gov/1827614/](https://pubmed.ncbi.nlm.nih.gov/1827614/) Kalivas, J., Breneman, Tharp, M. Bruce, S., & Bigby, M. (1990). Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine J Allergy Takahagi, S., Niimi, N., & Hide, M. (2007). Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients. Br J Dermatol, 157(4), 803-804. [https://doi.org/10.1111/j.1365-2133.2007.08060.x](https://doi.org/10.1111/j.1365-2133.2007.08060.x) Kaplan, A.P. (2002). Clinical practice. Chronic angioedema. New England Journal of Medicine, 346(3), 175-179. S.t., & G. (2005). Once-daily fexofenadine idiopathic urticaria: R.K. (2008). Treatment Clin Immunol, 122(3), Asthma Immunol Res, 4(6), 326-331. Raimundo, ... Zazzli, J.L. (2016). Timing and duration of omalizumab response in patients with chronic spontaneous urticaria. J Immunol, Pichler, W.J. (2006). Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, [https://doi.org/10.1111/j.1365-4632.2005.02609.x](https://doi.org/10.1111/j.1365-4632.2005.02609.x) Kawashima, M., & Harada, M. (2001). Efficacy and safety of fexofenadine HCl in Japanese patients with chronic idiopathic urticaria. Allergy Immunol, 124, 343-345. Bamberger E., & Toubi, E. (2005). Tacrolimus in the treatment of severe chronic idiopathic urticaria: An Cyclosporine-A in severe chronic urticaria: the option for long-term therapy. Allergy, 65(11), 1478-1482. [https://doi.org/10.1111/j.1398-9995.2010.02419.x](https://doi.org/10.1111/j.1398-9995.2010.02419.x) Khakoo, G., Sofianou-Katsoulis, A., Perkin, M.R., & Lack, G. (2008). Clinical features and natural history of physical urticaria in a Histamine-Reducing Diet for Some Patients with Chronic Urticaria & Maurer M. (2017). Autoimmune chronic spontaneous urticaria: What we know and what we do not know. C.E. (2011). Childhood acute urticaria in northern and southern Europe shows a similar epidemiological pattern and significant meteorological influences. Pediatr Allergy Daniilidis, M. (2016). Self-reported hair loss in patients with chronic spontaneous urticaria treated with omalizumab: an under-reported, transient Papageorgiou, C., ... Maurer, M. (2013). Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria. Dermatology K., ... Kullavanijaya P. (2001). Multicenter study of the efficacy and safety of fexofenadine 60mg twice daily in 108 Thai patients with chronic urticaria. J Med P., Chularojanamontri, L., & Maurer, M. (2018). Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Chang, E., & Luskin, A. (2016) Corticosteroid-related toxicity in patients with chronic Kim, M.A., ... Han, H.Y., (2017). Prevalence and risk factors of urticaria with a focus on chronic urticaria in children. Allergy Immunol Res, 9(3), 212-219. V., Maleville, J. (1990). Urticaria in infants: a chronic urticaria and angioedema with thyroid autoimmunity: a study 90 Anaphylactic reactions associated with omalizumab administration: Analysis of a case control study. J Allergy Clin Immunol 138(3), 913-915. [https://doi.org/10.1016/j.jaci.2016.03.030](https://doi.org/10.1016/j.jaci.2016.03.030) Lindsay, K., Goulding, J., Solomon, M., & Broom, B. (2015). Treating chronic spontaneous urticaria using a brief 'whole person' treatment approach: a Tsai, Y.G., Fu, Y.C., Wu, T.K., & Wu, H.P. (2010). Significant factors associated with severity and outcome of an initial episode of acute urticaria in children. Pediatr Allergy Immunol, Bradley, M.S., ... Szefler, S.J. (2014). Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab. Urticaria/Chronic Spontaneous Urticaria Following Return of Symptoms: Primary Results of the OPTIMA Study EADV. Poster abstract presented at the Clinical Dermatology Conference. Magen, E., & Mishal, J. (2012). The effect of L-thyroxine treatment on chronic idiopathic urticaria a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective 78-83. [https://doi.org/10.1111/j.1398-9995.2009.02130.x](https://doi.org/10.1111/j.1398-9995.2009.02130.x) [Malanin, G](http://www.ncbi.nlm.nih.gov/pubmed/?term=Malanin%20G%5BAuthor%5D&cauthor=true&cauthor_uid=2790561)., & [Kalimo, K](http://www.ncbi.nlm.nih.gov/pubmed/?term=Kalimo%20K%5BAuthor%5D&cauthor=true&cauthor_uid=2790561). (1989). Results of skin testing with food additives and the effect of an elimination diet in chronic and recurrent urticaria and recurrent angioedema. Successful treatment idiopathic urticaria with sulfasalazine. M. (2014). Retreatment with omalizumab results in rapid remission effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis. [https://doi.org/10.1016/j.jdermsci.2013.08.011](https://doi.org/10.1016/j.jdermsci.2013.08.011) Mitzel-Kaoukhov, high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous Immunol P., Zuberbier, T., Maurer, M. (2008). How to assess disease activity in patients with chronic urticaria? Allergy (6), 777-780. [http://dx.doi.org/10.1111/j.1398-9995.2008.01726.x](http://dx.doi.org/10.1111/j.1398-9995.2008.01726.x) Monroe, E.W., Cohen, S.H., Kalbfleisch, & Schulz, C.I. (1981). Combined H1 Arch (1988). Efficacy and safety of loratadine (10mg once daily) in the management of Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol, 108, 20-24. [https://doi.org/10.1016/j.anai.2011.09.008](https://doi.org/10.1016/j.anai.2011.09.008) Maurer, M., Altrichter, S., Bieber, T., (2011). Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol, 202e205-209e205. Gimenez-Arnau, A., ... Casale. T., (2013). Omalizumab for the treatment of chronic for insight. JAMA Derm, 153(12), 1221-1222. [http://doi:10.1001/jamadermatol.2017.3183](http://doi:10.1001/jamadermatol.2017.3183) Monroe, E.W. (1992). Relative efficacy and safety of loratadine, hydroxyzine, and placebo efficacy and safety of loratadine, hydroxyzine and placebo in chronic idiopathic urticaria. Arzneimittelforschung, Monroe, E., Finn, A., Patel, P., Guerrero, R., Ratner, P., & Bernstein, D. (2003). Efficacy and safety of desloratadine 5mg once daily in the treatment of chronic idiopathic Morgan, M., Cooke, A., Adams-Huet, B., & Khan, D.A. (2014). Double-blind J., & Taieb, A. (1998). Acute urticaria in infancy and early childhood: a prospective study. G., Y., Veith, J., & Andrews, E.B. (2015). The Xolair pregnancy registry (EXPECT): The safety of omalizumab use during Immunol, 135(2), 407-412. J. (2000). Fexofenadine HCl is safe and effective for treatment of chronic urticaria. Ann Allergy Ben-Shoshan, M. (2017). Evaluating comorbidities, natural history, and predictors of early resolution in a cohort of children with urticaria. Tursi, & Tursi, A. (2003). Efficacy of montelukast, in combination with loratadine, in the treatment of delayed urticaria. Desloratadine in combination with montelukast in the treatment of chronic & Tursi, (2006). Levocetirizine in treatment of chronic idiopathic hair loss in patients with chronic spontaneous urticaria treated with omalizumab. Eur Ann T., ... Weller, K. (2017). Responsiveness and minimal important difference of the urticaria control safety of sulfasalazine in patients with chronic idiopathic urticaria. J.J., Auquier, I. (2007). Efficacy and safety of desloratadine 5mg once daily in the treatment of chronic idiopathic (2001). Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food and/or acetylsalicylic acid. Allergy, Ashworth Friedmann treatment urticaria with terfenadine and ranitidine. A randomized double-blind J Clin Pharmacol, 277-280. [https://doi.org/10.1007/bf00981123](https://doi.org/10.1007/bf00981123) Perez, A., Methotrexate: a useful steroid-sparing Pitt, T., Warrington, treatment of chronic Efficacy of Hydroxychloroquine in the Treatment of 19 Patients with Antihistamine-refractory Chronic A.M., Hauptmann, P., & Finlay, A.Y. (2009). Comparison of the efficacy levocetirizine 5mg A.T., ... Huber, P.A. (2007). BSACI guidelines for the management use of mycophenolate mofetil to treat severe chronic urticaria in & Bosso, J. (2014). Prevalence of sensitivity to food and drug additives in patients with chronic idiopathic food ingredients. Dtsch Dermatol Ges, 7(1), 70-77. [https://doi.org/10.1111/j.1610-0387.2008.06894.x](https://doi.org/10.1111/j.1610-0387.2008.06894.x) Reeves, G., Boyle, M., Bonfield, J., Dobson, P., & Loewenthal, M. (2004). Impact of hydroxycholoroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Internal Medicine Journal, 34(4),182-186. [https://doi.org/10.1111/j.1444-0903.2004.00532.x](https://doi.org/10.1111/j.1444-0903.2004.00532.x) Reider, N., & Egger, C. (2009). Infliximab in the treatment of & Yawalkar, N. (2002). Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin Ring, J., Hein, R., Gauger, A., Bronsky, E., & Miller, B. (2001). Once-daily desloratadine improves the signs and symptoms of chronic idiopathic supplemental vitamin D3 treatment in chronic urticaria: a of urticaria with food additives intolerance means of diet. 57-62. [https://doi.org/10.1159/000250331](https://doi.org/10.1159/000250331) Rumbyrt, J.S., Resolution of chronic urticaria in patients with thyroid autoimmunity. J (2004). The etiology childhood. Trau, H., & Barzilai, A. (2011). Evidence for methotrexate as a useful Sekerel, B.E. (2011). Chronic urticaria: etiology and natural course 156(2), 224-230. [https://doi.org/10.1159/000322349](https://doi.org/10.1159/000322349) Saini, S.S., & D.A., Conner, E., Kaplan, A., Spector, S., & Maurer, M. (2011). A randomized, placebo-controlled, dose-ranging Bradley, M.S., ... Rosen, K. (2015). Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 Samarasinghe, V., & Marsland, A.M. (2012). Class action of oral coumarins in the treatment of a patient with chronic Inhibitors for Chronic Urticaria: Experience in 20 Patients. J Allergy (Cairo), 130905. [https://dx.doi.org/10.1155%2F2013%2F130905](https://dx.doi.org/10.1155%2F2013%2F130905) Shahar, E., Bergman, R., Guttman-Yassky, E., & Pollack, S. (2006). Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. International Journal of Dermatology, 45, 1224-1227. Z., & Hindmarch, I. (2000). Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios. Human Psychopharmacol, 15(s1), s3-s30. Shamsi, Z., & and antihistamines: a review of inter-drug differences using ratios. Psychopharmacol, (2014). A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment (1993). In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone. Br J Dermatol, 129(5), 575-579. [https://doi.org/10.1111/j.1365-2133.1993.tb00487.x](https://doi.org/10.1111/j.1365-2133.1993.tb00487.x) Shin, M., & Lee, S., (2017). Prevalence and causes of childhood urticaria. Allergy, Asthma & Research, M. (2009). High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard dose treatment in patients with acquired cold urticaria: a randomized, F.E. (2001). S., & Leahy, M.J. (2007). The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic M.K. (2010). The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Br Weller, K., ... Maurer, M. (2011). High prevalence of mental disorders and emotional distress in patients with chronic spontaneous Maurer, (2016). chronic spontaneous urticaria patients: results 1134-1144. [https://doi.org/10.1111/all.12870](https://doi.org/10.1111/all.12870) Barron, C., Bian, Caron-Guay, R.M., Laflamme, S., & Stern, S. (2014). [Real-life experiences with omalizumab for the treatment of chronic urticaria.](http://www.ncbi.nlm.nih.gov/pubmed/24468258) Ann Allergy Asthma Immunol, 112(2), 170-174. [https://doi.org/10.1016/j.anai.2013.12.005](https://doi.org/10.1016/j.anai.2013.12.005) Tal, Y., Toker, O., Agmon-Levin, N., & Shalit, M. (2014). Azathioprine as a therapeutic alternative for refractory chronic urticaria. of 60mg twice-daily fexofenadine HCl on quality of life work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am P., French, L., & Buchi, S. (2011). The Pictorial Representation of Illness and Self Measure (PRISM) instrument reveals a high burden of suffering in patients with chronic E, Nusem D, Panasoff J. (2004). Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy, 59, 869-873. [https://doi.org/10.1111/j.1398-9995.2004.00473.x](https://doi.org/10.1111/j.1398-9995.2004.00473.x) Vadasz, Z., Tal, Y., Y., for severe chronic spontaneous urticaria: J 1743-1745. [https://doi.org/10.1016/j.jaip.2017.08.035](https://doi.org/10.1016/j.jaip.2017.08.035) Van den Elzen, M., Os-Medendorp, H., van den Brink, I., Hurk, K., Kouznetsova, O.I., ... Knulst, A.C. (2017). Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria. Clinical and Translational Allergy, 7(4). Munisamy, M., Revathy, G., & Thappa D. M. (2016) Association among stress, hypocortisolism, systemic inflammation, and disease severity in chronic urticaria. Ann Allergy Asthma Immunol. in chronic idiopathic a Wagner, N., Dirk, D., Peveling-Oberhag, A., Reese, I., Rady-Pizarro, U., Mitzel, H., & Staubach, P. (2017). A Popular myth - low-histamine diet improves chronic spontaneous urticaria - fact antagonist with an anti-H1 receptor antagonist for treatment chronic urticaria. J Dermatolog Treat, 20, 194-197. [https://doi.org/10.1080/09546630802607495](https://doi.org/10.1080/09546630802607495) Wan, K.S., Chang, (2014). Efficacy of leukotriene antagonist with anti-H1 receptor antagonist plus Staubach, P., & Maurer M. (2013). Development, Validation and Initial Results of the Angioedema Activity Score. Allergy, 68(9),1185-1192. [https://doi.org/10.1111/all.12209](https://doi.org/10.1111/all.12209) Weller, M., Maurer, and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing and for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience. Mayo Clinic Proceedings 80, 41-47. [https://doi.org/10.4065/80.1.41](https://doi.org/10.4065/80.1.41) Wilson, L.H., Eliason, M.J., Leiferman, K.M., Hull, Powell, D.L. (2011). Treatment of refractory chronic urticaria with tumor necrosis factor alfa inhibitors. J Am Acad Dermatol. 64(6), 1221-1222. N.A. (2012). The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients. Journal of the American Academy of Dermatology, 66, 767-770. [https://doi.org/10.1016/j.jaad.2011.06.004](https://doi.org/10.1016/j.jaad.2011.06.004) Zitelli, K.B., & Maurer, M. (2009). The EAACI/GA2LEN/EDF/WAO urticaria. Allergy, [https://doi.org/10.1111/j.1398-9995.2009.02179.x](https://doi.org/10.1111/j.1398-9995.2009.02179.x) Zuberbier, T., Balke, M., Worm, Edenharter, & Maurer, M. (2010). Epidemiology of Urticaria; D., Ballmer-Weber, B., ... Maurer, M. (2018). The EAACI/GA2LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision ASCIA ASCIA is the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand. ASCIA resources are based on published literature and expert review, however, they are not intended to replace medical advice. The content of ASCIA resources is not influenced by any commercial organisations. For more information go to [www.allergy.org.au](https://www.allergy.org.au) To donate to "}